ENTERO1,850.00

Entero Healthcare Solutions Ltd.

· Consumer Services
₹ CrorePeersMEDPLUSEMILCRIZACGPPLCMSINFOHEMIPROPBLACKBUCKINOXGREENMcap ₹8,050 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth+29.9+29.3
EBITDA Growth+53.4+55.0
EBIT Growth+62.2+58.1
Net Income Growth+169.9+35.7
EPS Growth+101.7+21.3
Total Assets Growth+15.2+33.2
Total Equity Growth+7.9-1.0
Cash from Operations Growth-109.9+225.2
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.